Literature DB >> 18006833

Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis.

Carmen Segrelles1, Jerry Lu, Brian Hammann, Mirentxu Santos, Marta Moral, José Luis Cascallana, M Fernanda Lara, Okkyung Rho, Steve Carbajal, Jeanine Traag, Linda Beltrán, Ana Belén Martínez-Cruz, Ramón García-Escudero, Corina Lorz, Sergio Ruiz, Ana Bravo, Jesús M Paramio, John DiGiovanni.   

Abstract

Aberrant activation of the phosphoinositide-3-kinase (PI3K)/PTEN/Akt pathway, leading to increased proliferation and decreased apoptosis, has been implicated in several human pathologies including cancer. Our previous data have shown that Akt-mediated signaling is an essential mediator in the mouse skin carcinogenesis system during both the tumor promotion and progression stages. In addition, overexpression of Akt is also able to transform keratinocytes through transcriptional and posttranscriptional processes. Here, we report the consequences of the increased expression of Akt1 (wtAkt) or constitutively active Akt1 (myrAkt) in the basal layer of stratified epithelia using the bovine keratin K5 promoter. These mice display alterations in epidermal proliferation and differentiation. In addition, transgenic mice with the highest levels of Akt expression developed spontaneous epithelial tumors in multiple organs with age. Furthermore, both wtAkt and myrAkt transgenic lines displayed heightened sensitivity to the epidermal proliferative effects of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) and heightened sensitivity to two-stage skin carcinogenesis. Finally, enhanced susceptibility to two-stage carcinogenesis correlated with a more sustained proliferative response following treatment with TPA as well as sustained alterations in Akt downstream signaling pathways and elevations in cell cycle regulatory proteins. Collectively, the data provide direct support for an important role for Akt signaling in epithelial carcinogenesis in vivo, especially during the tumor promotion stage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18006833     DOI: 10.1158/0008-5472.CAN-07-2564

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

Review 1.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

2.  Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  L Allyson Checkley; Okkyung Rho; Tricia Moore; Steve Hursting; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2011-07

3.  Rapamycin and mTORC1 inhibition in the mouse: skin cancer prevention.

Authors:  Mohammad Athar; Levy Kopelovich
Journal:  Cancer Prev Res (Phila)       Date:  2011-07

4.  Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma.

Authors:  Janine G Einspahr; Valerie Calvert; David S Alberts; Clara Curiel-Lewandrowski; James Warneke; Robert Krouse; Steven P Stratton; Lance Liotta; Caterina Longo; Giovanni Pellacani; Giovanni Pellicani; Anil Prasad; Paul Sagerman; Yira Bermudez; Jianghong Deng; G Timothy Bowden; Emanuel F Petricoin
Journal:  Cancer Prev Res (Phila)       Date:  2012-03

5.  Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma.

Authors:  Marta Moral; Carmen Segrelles; M Fernanda Lara; Ana Belén Martínez-Cruz; Corina Lorz; Mirentxu Santos; Ramón García-Escudero; Jerry Lu; Kaoru Kiguchi; Agueda Buitrago; Clotilde Costa; Cristina Saiz; Jose L Rodriguez-Peralto; Francisco J Martinez-Tello; Maria Rodriguez-Pinilla; Montserrat Sanchez-Cespedes; Marina Garín; Teresa Grande; Ana Bravo; John DiGiovanni; Jesús M Paramio
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

6.  Pten loss induces autocrine FGF signaling to promote skin tumorigenesis.

Authors:  Kristina Hertzler-Schaefer; Grinu Mathew; Ally-Khan Somani; Sunil Tholpady; Madhavi P Kadakia; Yiping Chen; Dan F Spandau; Xin Zhang
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

7.  Transgenic mice expressing constitutively active Akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma.

Authors:  Marta Moral; Carmen Segrelles; Ana Belén Martínez-Cruz; Corina Lorz; Mirentxu Santos; Ramón García-Escudero; Jerry Lu; Agueda Buitrago; Clotilde Costa; Cristina Saiz; José M Ariza; Marta Dueñas; Jose L Rodriguez-Peralto; Francisco J Martinez-Tello; Maria Rodriguez-Pinilla; Montserrat Sanchez-Cespedes; John Digiovanni; Jesús M Paramio
Journal:  In Vivo       Date:  2009 Sep-Oct       Impact factor: 2.155

8.  Constitutively active Akt induces ectodermal defects and impaired bone morphogenetic protein signaling.

Authors:  Carmen Segrelles; Marta Moral; Corina Lorz; Mirentxu Santos; Jerry Lu; José Luis Cascallana; M Fernanda Lara; Steve Carbajal; Ana Belén Martínez-Cruz; Ramón García-Escudero; Linda Beltran; José C Segovia; Ana Bravo; John DiGiovanni; Jesús M Paramio
Journal:  Mol Biol Cell       Date:  2007-10-24       Impact factor: 4.138

9.  Strain-induced proliferation requires the phosphatidylinositol 3-kinase/AKT/glycogen synthase kinase pathway.

Authors:  Christopher P Gayer; Lakshmi S Chaturvedi; Shouye Wang; David H Craig; Thomas Flanigan; Marc D Basson
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

10.  Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish.

Authors:  Bensheng Ju; Jan Spitsbergen; Christopher J Eden; Michael R Taylor; Wenbiao Chen
Journal:  Mol Cancer       Date:  2009-06-25       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.